KRAS and lung cancer: Non–small-cell lung cancer (NSCLC) is the most prevalent form of cancer in the western world, and ∼35% of all patients exhibit mutations in Kras, a key component of the Ras pathway (Cancer Genome Atlas Research Network, 2014; Chen et al., 2014).